<DOC>
	<DOCNO>NCT00000788</DOCNO>
	<brief_summary>To evaluate pharmacokinetics safety concomitant administration methadone fluconazole . Injection drug user constitute second large subset U.S. population risk HIV infection AIDS-associated mortality . Narcotic addiction often treat use methadone . Fluconazole show highly effective treat symptomatic mucosal candidiasis , unknown whether fluconazole affect methadone metabolism , could result symptom methadone withdrawal overdose patient take drug combination .</brief_summary>
	<brief_title>A Study Assess Effect Concomitant Administration Fluconazole Clinical Pharmacokinetics Methadone</brief_title>
	<detailed_description>Injection drug user constitute second large subset U.S. population risk HIV infection AIDS-associated mortality . Narcotic addiction often treat use methadone . Fluconazole show highly effective treat symptomatic mucosal candidiasis , unknown whether fluconazole affect methadone metabolism , could result symptom methadone withdrawal overdose patient take drug combination . Patients randomize receive methadone plus either fluconazole placebo clinic daily 16 day . Study drug administer close 8 AM possible . Patients must visit Fort Greene clinic study day 1 , 2 , 15 , 16 ; may receive treatment home clinic day 3 14 .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Antiretroviral therapy . Intermittent acetaminophen , aspirin , ibuprofen . Patients must : CD4 count &gt; = 250 cells/mm3 within 3 month prior study entry . Received stable dose methadone minimum 30 day prior study entry . Negative urine toxicology screen ( except methadone methadone metabolite ) within 14 day prior study entry . Reasonably good health . Life expectancy least 6 month . Ability willingness comply protocol requirement . NOTE : Patients recruit methadone maintenance treatment program currently administer Addiction Research Treatment Corporation . Enrollment woman encourage . NOTE : Patients currently enrol CPCRA treatment prophylaxis trial eligible study provide permanently remove study drug protocol . Prior Medication : Required : Stable dose methadone minimum 30 day prior study entry . Allowed : Prior antiretroviral therapy ( dose stable 14 day prior study entry ) . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Known sensitivity azoles , methadone , opiate narcotic . Concurrent Medication : Excluded : Amiodarone . Anesthetics , general . Barbiturates . Carbamazepine . Cimetidine . Ciprofloxacin . Dexamethasone . Disulfiram . Erythromycin . Fluoroquinolones . Fluoxetine . Gestodene . Hydrochlorothiazide . Hypoglycemics , oral . Isoniazid . Itraconazole . Ketoconazole . Levomepromazine . MAO inhibitor . Methoxsalen . Nafcillin . Narcotic analgesic . Naringenin . Norethindrone . Omeprazole . Pentazocine . Phenothiazines . Phenytoin . Quinidine . Ranitidine . Rifabutin . Rifampin . Sedative hypnotic . Sulfaphenazole . Tranquilizers . Tricyclic antidepressant . Troleandomycin . Warfarin . Prior Medication : Excluded within 30 day prior study entry : Ketoconazole , fluconazole , itraconazole . Experimental drug . Alcohol illicit drug abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Methadone</keyword>
	<keyword>Drug Interactions</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Fluconazole</keyword>
	<keyword>Antifungal Agents</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
</DOC>